Clinical Trial Update: Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ofatumumab-based regimens for newly diagnosed mantle cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYTARABINE (CYTARABINE)
• DEXAMETHASONE (Dexamethasone)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• METHOTREXATE (METHOTREXATE)
• Ofatumumab (ofatumumab)
• Vincristine sulfate (VINCRISTINE SULFATE)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Stage I Mantle Cell Lymphoma, Stage II Contiguous Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-06-23